Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$3.94 - $7.09 $26,953 - $48,502
-6,841 Closed
0 $0
Q4 2020

Feb 05, 2021

SELL
$5.45 - $8.65 $267 - $423
-49 Reduced 0.71%
6,841 $41,000
Q3 2020

Oct 30, 2020

SELL
$4.34 - $11.43 $1,579 - $4,160
-364 Reduced 5.02%
6,890 $51,000
Q2 2020

Jul 22, 2020

SELL
$1.85 - $5.29 $5,222 - $14,933
-2,823 Reduced 28.01%
7,254 $29,000
Q1 2020

May 14, 2020

SELL
$1.24 - $4.35 $866 - $3,040
-699 Reduced 6.49%
10,077 $26,000
Q4 2019

Feb 10, 2020

BUY
$2.3 - $5.12 $24,784 - $55,173
10,776 New
10,776 $38,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $131M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.